Statin-induced hepatocellular patterns of liver injury Definition and epidemiology Statin-induced liver injury has been associated with both hepatocellular and cholestatic patterns of injury
The primary endpointchange in Clinical Dementia Rating Sum of Boxes (CDR-SB)showed no significant difference between groups
Eat Low-Fat, Small Meals Fat is the hardest macronutrient for your GI tract to process during GLP-1 therapy
The primary challenges include designing an appropriate dosing schedule for consistent exposure, precisely timing sample collections, and ensuring subject compliance with frequent administrations
Triple agonists add glucagon receptor activation, which: Increases resting energy expenditure by 8% to 12% (Jall et al., Diabetes Care 2024) Promotes hepatic fat oxidation and reduces steatosis May offset some of the lean mass loss seen with GLP-1 monotherapy (early signal, not yet confirmed in long-term trials) The weight loss ceiling for retatrutide appears to be 24% to 26% based on phase 3 data, though long-term real-world outcomes are not yet available
Another area of interest is gastrointestinal support
